Introducing Estrogen Metabolism as the Main Target of Wedelia chinensis in Prostate Cancer Cells

被引:0
作者
Mansouri, Vahid [1 ]
Khodadoost, Mahmood [2 ,3 ]
Robati, Reza Mahmoud [4 ]
Razzaghi, Zahra [5 ]
Rezaei, Mitra [6 ]
机构
[1] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Prote Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Tradit Med & Mat Med Res Ctr, Sch Tradit Med, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Tradit Med, Dept Tradit Med, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Skin Res Ctr, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Laser Applicat Med Sci Res Ctr, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Genom Res Ctr, Tehran, Iran
关键词
estrogen; gene; pathway; prostate cancer; Wedelia; ANDROGEN RECEPTOR; GROWTH; INHIBITION;
D O I
10.22127/RJP.2023.376910.2026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and objectives: Investigations indicate that Wedelia chinensis extract increases efficacy of prostate cancer treatment. In the present study, the differentially expressed genes (DEGs) of prostate cancer cell line 22RV1 in the presence of W. chinensis extract derived from Gene Expression Omnibus (GEO) were evaluated by gene ontology and pathway analysis.Methods: Gene expression profiles of GSE100224 were analyzed by GEO2R. The significant DEGs were assessed via action map analysis. The related biological terms were identified for the significant DEGS. The highlighted dysregulated genes and pathways were discussed. Results: Seventy significant DEGs including 49 up -regulated genes and 21 down-regulated ones were assessed by inhibition, activation, expression, and binding actions. Cytochrome P450 and PTGS2 were highlighted as the crucial DEGs. Estrogen metabolism was pointed as the main targeted pathway.Conclusion: Findings indicated that "estrogen metabolism" and UGT1A1, MAOA, PTSG2, and cytochrome P450 in the 22RV1 cells were the main targeted pathway and genes by W. chinensis.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 50 条
  • [31] STAT3 as a target for sensitizing prostate cancer cells to irradiation
    Zhang, Qu
    Zhou, Xiao-Mei
    Wei, Shao-Zhong
    Cui, Dian-Sheng
    Deng, Kang-Li
    Liang, Gai
    Luo, Yan
    Luo, Bo
    Liang, Xin-Jun
    JOURNAL OF RADIATION RESEARCH, 2022, 63 (02) : 174 - 182
  • [32] Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
    Hayashi, Takuji
    Fujita, Kazutoshi
    Matsushita, Makoto
    Nonomura, Norio
    CANCERS, 2019, 11 (08)
  • [33] CXCR4 Is a Novel Target of Cancer Chemopreventative Isothiocyanates in Prostate Cancer Cells
    Sakao, Kozue
    Vyas, Avani R.
    Chinni, Sreenivasa R.
    Amjad, Ali I.
    Parikh, Rahul
    Singh, Shivendra V.
    CANCER PREVENTION RESEARCH, 2015, 8 (05) : 365 - 374
  • [34] Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer
    Clara H. Lee
    Ann M. Decker
    Frank C. Cackowski
    Russell S. Taichman
    Cell Biology and Toxicology, 2020, 36 : 115 - 130
  • [35] Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism
    Shahid, Muhammad
    Kim, Minhyung
    Lee, Min Young
    Yeon, Austin
    You, Sungyong
    Kim, Hyung L.
    Kim, Jayoung
    PROTEOMICS, 2019, 19 (11)
  • [36] Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
    B. Meller
    F. Bremmer
    C. O. Sahlmann
    S. Hijazi
    C. Bouter
    L. Trojan
    J. Meller
    P. Thelen
    EJNMMI Research, 5
  • [37] Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
    Meller, B.
    Bremmer, F.
    Sahlmann, C. O.
    Hijazi, S.
    Bouter, C.
    Trojan, L.
    Meller, J.
    Thelen, P.
    EJNMMI RESEARCH, 2015, 5 : 1 - 11
  • [38] Introducing a simple model system for binding studies of known and novel inhibitors of AMPK: a therapeutic target for prostate cancer
    Kumar, Rakesh
    Maurya, Ranjana
    Saran, Shweta
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (03) : 781 - 795
  • [39] Vitamin D metabolism in human prostate cells: Implications for prostate cancer chemoprevention by vitamin D
    Flanagan, John N.
    Young, Michael V.
    Persons, Kelly S.
    Wang, Lilin
    Mathieu, Jeffrey S.
    Whitlatch, Lyman W.
    Holick, Michael F.
    Chen, Tai C.
    ANTICANCER RESEARCH, 2006, 26 (4A) : 2567 - 2572
  • [40] Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells
    Pisolato, R.
    Lombardi, A. P. G.
    Vicente, C. M.
    Lucas, T. F. G.
    Lazari, M. F. M.
    Porto, C. S.
    STEROIDS, 2016, 107 : 74 - 86